Download Current Issue (PDF)
Clues to fighting cancer are being revealed through genomic analysis, which looks at the DNA of cancer cells for mutations to target. A new Genomics Tumor Board at MUSC hopes to outwit "smart" cancers.
Anand Mehta, DPhil, a leader in the development of glycoproteomic technologies for the discovery of novel cancer biomarkers is the new SmartState Endowed Chair of Proteomic Biomarkers at the Medical University of South Carolina.
See recent peer-reviewed publications from HCC physicians, researchers and postdoctoral trainees.